Home › Therapeutic areas › Neurology › Migraine
Migraine (4 companies)
Companies with an active program in Migraine.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics | Neurology Rare | 1 | Approved | $7.15B | 15 |
| ENTA | Enanta Pharmaceuticals | DermatologyImmunology+2 | 1 | Approved | $253M | 8 |
| EVMN | Evommune | DermatologyImmunology+1 | 1 | Phase 2 | $290M | 6 |
| RAPP | Rapport Therapeutics | Neurology | 1 | Phase 3 | $1.41B | 6 |
No companies match.